4//SEC Filing
Kelley Kenneth J 4
Accession 0001179110-21-004416
CIK 0001159036other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:19 PM ET
Size
4.8 KB
Accession
0001179110-21-004416
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Sale
Common Stock
2021-04-14$45.00/sh−5,000$225,000→ 179,833 total
Footnotes (1)
- [F1]This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001291219
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:19 PM ET
- Size
- 4.8 KB